IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA recommends limits on use of Alzheimer’s drug amid backlash


Only one month after the FDA’s controversial approval of the first Alzheimer’s treatment since 2003, the agency is now calling for limits on who gets the drug. NBC News medical correspondent Dr. John Torres joins TODAY to explain what the news means for those living in Alzheimer’s.